How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Bizengri is given by a doctor or nurse, not picked up at a pharmacy.

What to do

  1. Ask your care team or your plan what you’d pay before your visit.

Your care team and your insurance decide which product you get.

Compare every option

Brand name

Bizengri, the original

Cash priceAsk the pharmacy
Ways to save on Bizengri

The maker’s card

PTx Assist Co-Pay Assistance Program

Savings card from Merus

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $10 a dose

The card takes up to $25,000 a year off your co-pay.

Sign up on ptxassist.com 

Or call 1-877-353-8546. See the offer on ptxassist.com

In the maker’s words

“If you have commercial insurance, and qualify for this program, you may be able to reduce your out-of-pocket costs to as little as $0 for the first dose and $10 for subsequent doses…”

From the maker’s offer on ptxassist.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Bizengri is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldAsk the pharmacy

What it’s used for

What the FDA label says

BIZENGRI® is a bispecific HER2- and HER3-directed antibody indicated for the treatment of:

  • Adults with advanced, unresectable or metastatic non-small cell lung cancer (NSCLC) harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior systemic therapy.*
  • Adults with advanced, unresectable or metastatic pancreatic adenocarcinoma harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior systemic therapy.*
  • Adults with advanced, unresectable or metastatic cholangiocarcinoma harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior systemic therapy.
  • This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Bizengri (Partner Therapeutics, Inc.), May 19, 2026. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.